Literature DB >> 31566661

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

O Michielin1, A C J van Akkooi2, P A Ascierto3, R Dummer4, U Keilholz5.   

Abstract

Entities:  

Keywords:  clinical practice guidelines; cutaneous melanoma; diagnosis; treatment, follow-up

Year:  2019        PMID： 31566661     DOI： 10.1093/annonc/mdz411

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  83 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

Review 2.  The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis.

Authors:  Narjess Ayati; Ramin Sadeghi; Zahra Kiamanesh; Sze Ting Lee; S Rasoul Zakavi; Andrew M Scott
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-29       Impact factor: 9.236

3.  Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).

Authors:  Alexander C J van Akkooi; Tina J Hieken; Elizabeth M Burton; Andrew J Spillane; Merrick I Ross; Charlotte Ariyan; Paolo A Ascierto; Salvatore V M A Asero; Christian U Blank; Matthew S Block; Genevieve M Boland; Corrado Caraco; Sydney Chng; B Scott Davidson; Joao Pedreira Duprat Neto; Mark B Faries; Jeffrey E Gershenwald; Dirk J Grunhagen; David E Gyorki; Dale Han; Andrew J Hayes; Winan J van Houdt; Giorgos C Karakousis; Willem M C Klop; Georgina V Long; Michael C Lowe; Alexander M Menzies; Roger Olofsson Bagge; Thomas E Pennington; Piotr Rutkowski; Robyn P M Saw; Richard A Scolyer; Kerwin F Shannon; Vernon K Sondak; Hussein Tawbi; Alessandro A E Testori; Mike T Tetzlaff; John F Thompson; Jonathan S Zager; Charlotte L Zuur; Jennifer A Wargo
Journal:  Ann Surg Oncol       Date:  2022-01-28       Impact factor: 5.344

4.  Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma.

Authors:  Lisa Haas; Anais Elewaut; Camille L Gerard; Christian Umkehrer; Lukas Leiendecker; Malin Pedersen; Izabela Krecioch; David Hoffmann; Maria Novatchkova; Mario Kuttke; Tobias Neumann; Ines Pires da Silva; Harriet Witthock; Michel A Cuendet; Sebastian Carotta; Kevin J Harrington; Johannes Zuber; Richard A Scolyer; Georgina V Long; James S Wilmott; Olivier Michielin; Sakari Vanharanta; Thomas Wiesner; Anna C Obenauf
Journal:  Nat Cancer       Date:  2021-07-15

5.  Mediastinal and hilar sarcoid-like reaction in a patient treated with dabrafenib and trametinib for metastatic melanoma: A case report and review of the literature.

Authors:  Vanessa-Meletia Bala; Maria Mitsogianni; Konstantinos Laschos; Evangelia Pliakou; Eirini Lazaridi; Dimitra-Ioanna Lampropoulou; Gerasimos Aravantinos
Journal:  Mol Clin Oncol       Date:  2022-03-18

6.  Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma, and Cutaneous Melanoma.

Authors:  Sam El Abbadi; Laura Susok; Egger Stockfleth; Falk Georges Bechara; Thilo Gambichler; Swetlana Herbrandt; Lisa Goldschmidtböing; Michael Sand
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-13

7.  The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.

Authors:  Doreen Z Mhandire; Andrew K L Goey
Journal:  Mol Diagn Ther       Date:  2022-02-03       Impact factor: 4.074

Review 8.  Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients.

Authors:  Sarah Zhou; Daniel Sikorski; Honghao Xu; Andrei Zubarev; May Chergui; François Lagacé; Wilson H Miller; Margaret Redpath; Stephanie Ghazal; Marcus O Butler; Teresa M Petrella; Joël Claveau; Carolyn Nessim; Thomas G Salopek; Robert Gniadecki; Ivan V Litvinov
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 9.  Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.

Authors:  Vito Amodio; Gianluca Mauri; Nicole M Reilly; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli; Giovanni Germano
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

10.  Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study.

Authors:  Lisa Wiens; Norbert Schäffeler; Thomas Eigentler; Claus Garbe; Andrea Forschner
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.